Insider filing · AORT
James P Mackin
President & CEO
profile →
Artivion, Inc.
AORT · Healthcare · 59 filings in 24 months
ticker →
James P Mackin sold $1.4M of Artivion (AORT)
Executed Dec 2 2025, disclosed Dec 3 2025, 1 day later.
Value, as filed
$1.4M
30,921 sh × $45.56
Executed
Dec 2 2025
the trade date, as filed
Disclosed
Dec 3 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JMJames P Mackin (President & CEO) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Artivion, Inc. (AORT). The largest single filing was $2.0M of AORT (70,000 sh × $28.95, as filed), executed Aug 19.
The name
AORTHealthcare · Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by James P Mackin in AORT
AORTSALE
Artivion, Inc.
$2.0M70,000 sh × $28.95
Exec Aug 19
Filed Aug 20 · 2:11 PM ET AORTSALE Artivion, Inc. $676K
17,887 sh × $37.78
Exec Mar 3
Filed Mar 4 · 5:30 PM ET AORTSALE Artivion, Inc. $567K
14,911 sh × $38.02
Exec Mar 2
Filed Mar 3 · 5:30 PM ET AORTSALE Artivion, Inc. $1.3M
34,898 sh across 2 lots
Exec Feb 23
Filed Feb 25 · 5:30 PM ET AORTSALE Artivion, Inc. $1.4M
30,921 sh × $45.46
Exec Dec 3 2025
Filed Dec 4 2025 · 5:30 PM ET AORTSALE Artivion, Inc. $1.6M
34,210 sh × $45.86
Exec Nov 13 2025
Filed Nov 14 2025 · 5:30 PM ET AORTSALE Artivion, Inc. $784K
17,580 sh × $44.62
Exec Nov 10 2025
Filed Nov 12 2025 · 5:30 PM ET AORTSALE Artivion, Inc. $529K
12,500 sh × $42.32
Exec Aug 15 2025
Filed Aug 19 2025 · 5:30 PM ET